Blog - Page 3040 of 5453

MondayJan 23, 2012 5:03 pm

Amarantus BioSciences (AMBS) Inks License Agreement with Power3 (PWRM) for Parkinson’s Application

Amarantus Biosciences, Inc., a biotech company focused on developing a first-in-class disease–modifying therapeutic protein for the treatment of Parkinson’s disease, today announced it has signed an exclusive worldwide license agreement with Power3 Medical Products, Inc. for the NuroPro® Blood Test as it relates to Parkinson’s disease diagnosis. Per the initial one-year agreement, Amarantus has an exclusive license to develop, manufacture, have manufactured, use, market, sell and import medical devices and methods under the Power3 Parkinson’s Disease Intellectual Property (IP). Amarantus now also has an exclusive, royalty-free, fully paid-up worldwide license to Power3 know-how, patents and patent applications which relate to…

MondayJan 23, 2012 3:21 pm

Biostar Pharmaceuticals, Inc. (BSPM) Secures Key R&D Cooperation Agreement with Chinese Military Organization

Today, Biostar Pharmaceuticals, a leading provider of pharmaceuticals and health supplements, like the Company’s popular OTC offering for chronic hepatitis B (Xin AoXing Oleanolic Acid Capsule), reported special selection (at a January 8th ceremony) by the PLA’s Fourth Military Medical University (FMMU) for cooperation in ongoing research and product development activities. The FMMU has been a major force in the Chinese military medical landscape since its formation in 1954 (out of the 4th and 5th Military Medical Colleges), serving a vital role as one of only a handful of key institutions for training middle- to high-level medical personnel for the…

MondayJan 23, 2012 2:45 pm

PLC Systems (PLCSF) Treats First Patient in RenalGuard® Pivotal Trial

PLC Systems, Inc., a medical device company focused on innovative technologies for the cardiac and vascular markets, today announced it has completed the enrollment of the first patient in the CIN-RG trial designed to study the efficacy of its RenalGuard Therapy® and RenalGuard System™ for the prevention of Contrast-Induced Nephropathy (CIN). This achievement marks an important step toward obtaining U.S. Food and Drug Administration (FDA) approval to distribute RenalGuard® in the United States. "RenalGuard offers us the potential for a method to reduce the incidence of CIN while allowing me as an interventional cardiologist to focus on the catheterization without…

MondayJan 23, 2012 2:24 pm

FrogAds, Inc. (FROG) Aims for the Best Marketplace Site on the Web

Whether you are a vendor, or just an individual interested in selling something, the Web has become an unavoidable part of the marketing pie. Internet advertising revenues, despite the ups and downs inevitable with any developing technology, have essentially tripled in the past decade, and are now approaching $30 billion. But with all of the growth comes a problem. The Web represents an almost limitless ocean of information, including vendors and consumers. The problem has always been where do you go to get your message seen? FrogAds, Inc. believes it has the answer, and projected growth rates suggest that they…

MondayJan 23, 2012 12:50 pm

SmallCapVoice: GreenCell, Inc. (GCLL) Announces a New Method for Grinding Ultrafine / UltraPure Conductive Powders

GreenCell, Inc. has completed development on a new method for grinding Ultrafine / UltraPure conductive powders. Previous commercial methods produced a contaminant during grinding to the nano-scale level. The new method utilizes a clean ceramic as a ring grinder that has a density near lead. The new technology has been completed and tested for batch processing but a continuous grinding is possible in the future. This technology will be applied to GreenCell’s line of igniters, sensors, and fuel cell stacks. GreenCell is engaged in a joint venture with SenCer Inc. to develop, commercialize and market SenCer’s UltraTemp(TM) ceramic composite materials…

MondayJan 23, 2012 12:45 pm

SmallCapVoice: Juhl Wind, Inc. (JUHL) Selected as Development Partner for Upstate NY’s Black Oak Wind Project

Juhl Wind, Inc., the Leader in Community Wind Power, announced the signing of a Development Services Agreement with the Black Oak Wind Farm located near Ithaca, NY. The project is a proposed 15 to 30 MW facility with expectation of the project being online during the third quarter 2013. Juhl Wind will be serving as a development partner for the project. “We are very excited to be expanding our development services outside of the Midwest region. The Black Oak Wind Farm is made up of a group of highly motivated individuals who are looking to bring the Ithaca area its…

MondayJan 23, 2012 10:06 am

Cell Therapeutics, Inc. (CTIC) Video Chart for Monday, January 23, 2012

CTIC had a strong day on Friday, closing up nearly 15 percent. The indicators are bullish, and coupled with the increase in volume to end last week, puts the chart on technical watch to break through resistance at $1.30. To view the video chart, visit the following link: http://www.qualitystocks.net/videocharts Let us hear your thoughts below:

FridayJan 20, 2012 6:39 pm

Nexxus Lighting, Inc. (NEXS) Announces Full ENERGY STAR® Qualification for Two Array LED Light Bulbs

Nexxus Lighting Inc., a leader in high performance LED replacement light bulbs with its Array® Lighting line of products, today announced that the Array R30 3000K Flood and the 3000K Accent LED light bulbs can now be marketed with a life certification of 50,000 hours after receiving full ENERGY STAR qualification. In October of 2010, the bulbs earned the ENERGY STAR mark and now the final round of lumen maintenance testing demonstrates that each bulb will last the equivalent of 10 years when the lamp is on for twelve hours per day. "All of the Array LED bulbs are designed…

FridayJan 20, 2012 5:37 pm

FrogAds, Inc. (FROG) is “One to Watch” for Next Week

FrogAds, Inc. is a rapidly growing company focused on providing a simple yet revolutionary platform for online buying, selling and advertising. Through FrogAds.com, the company enables Internet users to list products and services at no charge in an easy and efficient manner by category and geographical area. The Web site also features online auctioning, photo/movie upload, banner exchange, affordable commercial advertising and more. From 2000 to 2010, Internet advertising revenues grew from $8.1 billion to over $26.0 billion. This tremendous growth has been attributed to the expanding number of Internet users, which has led to greater advertising success as well…

FridayJan 20, 2012 3:41 pm

La Jolla Pharmaceutical (LJPC) Announces Acquisition of Novel Therapeutic, Significant Management Changes

La Jolla Pharmaceutical Company, a biopharmaceutical company developing treatments to improve the outcome of patients with life-threatening diseases, today announced that it has acquired global development and commercialization rights to GCS-100, a novel therapeutic for cancer and chronic organ failure. GCS-100’s ongoing development as an anti-cancer and anti-fibrotic agent is supported by extensive preclinical and clinical investigation, including phase 1 and phase 2 clinical trials. La Jolla acquired GCS-100 from privately held Solana Therapeutics Inc. (Solana). In connection with the acquisition, former Solana CEO George F. Tidmarsh, M.D., Ph.D. will serve as La Jolla’s new president and CEO. “Having been…

Site Search

Company Search